Shanghai now plans to steer the company into the specialty business
(novel, innovative drugs), and towards expanding markets like China
and Japan for growth, both through acquisitions and partnerships.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-eyes-china-japan-mkts/articleshow/73150206.cms
No comments:
Post a Comment